This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04022/identifier/pubchem-compound/
n5http://linked.opendata.cz/resource/drugbank/drug/DB04022/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04022/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04022/identifier/chebi/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB04022/identifier/pdb/

Statements

Subject Item
n2:DB04022
rdf:type
n3:Drug
n3:description
Guanosine 5'-diphosphate 2'(3')-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I. [PubChem]
n3:group
experimental
owl:sameAs
n13:DB04022 n14:DB04022
dcterms:title
Guanosine-5',3'-Tetraphosphate
adms:identifier
n5:46508997 n8:G4P n9:46936862 n10:17633 n11:DB04022
n3:IUPAC-Name
n6:271B5988-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B598E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B598D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B598A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B598B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B598C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B5986-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B5984-363D-11E5-9242-09173F13E4C5 n6:271B5987-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B5985-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B5994-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B5995-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B598F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B5990-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B5992-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B5991-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B5993-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B599A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B599C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B599D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B5999-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B5998-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B599B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B5989-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B5996-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B5997-363D-11E5-9242-09173F13E4C5